Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – August 16
7:34 AM MDT | August 16, 2011 | Deepti Ramesh
REPORT: PHARMACEUTICAL CONTRACT MANUFACTURING REVENUES TO REACH $64 BILLION IN 2016 The global pharmaceutical contract manufacturing revenues will reach $64.07 billion in 2016, says a recent report by business information company Visiongain (London). Manufacturing of finished dosage forms will drive revenue growth, with the market expected to grow at a CAGR of 8.7% between 2010 and 2016. Revenues for this industry will more than double from 2011 to 2021. Active pharmaceutical ingredient (API) manufacturing remained the largest market sector in 2010, accounting...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee